Kiminori Terui

2.7k total citations
71 papers, 885 citations indexed

About

Kiminori Terui is a scholar working on Hematology, Molecular Biology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Kiminori Terui has authored 71 papers receiving a total of 885 indexed citations (citations by other indexed papers that have themselves been cited), including 48 papers in Hematology, 26 papers in Molecular Biology and 19 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Kiminori Terui's work include Acute Myeloid Leukemia Research (39 papers), Acute Lymphoblastic Leukemia research (18 papers) and RNA modifications and cancer (8 papers). Kiminori Terui is often cited by papers focused on Acute Myeloid Leukemia Research (39 papers), Acute Lymphoblastic Leukemia research (18 papers) and RNA modifications and cancer (8 papers). Kiminori Terui collaborates with scholars based in Japan, United States and Singapore. Kiminori Terui's co-authors include Etsuro Ito, Tsutomu Toki, Souichi Adachi, Rika Kanezaki, Junichi Kitazawa, Yasuhide Hayashi, Hirokazu Kanegane, Tomohiko Taki, Issay Kitabayashi and Akira Shimada and has published in prestigious journals such as Nature Medicine, Blood and Scientific Reports.

In The Last Decade

Kiminori Terui

62 papers receiving 869 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kiminori Terui Japan 19 504 380 194 170 143 71 885
Daniel H. Wiseman United Kingdom 15 337 0.7× 529 1.4× 60 0.3× 134 0.8× 104 0.7× 46 854
Anna Grazia Recchia Italy 16 302 0.6× 265 0.7× 154 0.8× 79 0.5× 151 1.1× 38 653
Jian‐Pei Fang China 14 301 0.6× 269 0.7× 118 0.6× 55 0.3× 201 1.4× 87 733
Sabine Knipp Germany 12 1.2k 2.3× 521 1.4× 192 1.0× 77 0.5× 535 3.7× 20 1.4k
A. O’Meara Ireland 13 207 0.4× 189 0.5× 136 0.7× 61 0.4× 139 1.0× 20 872
Christine von Neuhoff Germany 16 736 1.5× 302 0.8× 422 2.2× 37 0.2× 99 0.7× 24 889
Sélim Corm France 18 1.0k 2.0× 232 0.6× 199 1.0× 110 0.6× 715 5.0× 44 1.4k
Maria de Lourdes Chauffaille Brazil 13 237 0.5× 156 0.4× 68 0.4× 82 0.5× 246 1.7× 65 578
Sioḃán Keel United States 18 596 1.2× 558 1.5× 79 0.4× 149 0.9× 358 2.5× 53 1.3k
Kunitake Hirashima Japan 14 410 0.8× 218 0.6× 69 0.4× 86 0.5× 113 0.8× 44 698

Countries citing papers authored by Kiminori Terui

Since Specialization
Citations

This map shows the geographic impact of Kiminori Terui's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiminori Terui with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiminori Terui more than expected).

Fields of papers citing papers by Kiminori Terui

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kiminori Terui. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiminori Terui. The network helps show where Kiminori Terui may publish in the future.

Co-authorship network of co-authors of Kiminori Terui

This figure shows the co-authorship network connecting the top 25 collaborators of Kiminori Terui. A scholar is included among the top collaborators of Kiminori Terui based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kiminori Terui. Kiminori Terui is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sano, Hirozumi, Keitaro Fukushima, Michihiro Yano, et al.. (2024). Analysis of overweight/obese pediatric patients with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group AML-05 study. International Journal of Hematology. 119(6). 745–754.
2.
Kato, Shota, Kentaro Nakashima, Genki Yamato, et al.. (2024). Azacitidine treatment for myeloid leukemia associated with Down syndrome: A nationwide retrospective study in Japan. Pediatric Blood & Cancer. 71(10). e31244–e31244.
3.
Tanaka, Tatsuhiko, Ko Kudo, Rika Kanezaki, et al.. (2024). Antileukemic effect of azacitidine, a DNA methyltransferase inhibitor, on cell lines of myeloid leukemia associated with Down syndrome. Experimental Hematology. 132. 104179–104179. 2 indexed citations
4.
Watanabe, Ryota, Takao Sasaki, Shohei Kinoshita, et al.. (2023). Spontaneous remission of skull Langerhans cell histiocytosis that had developed by repeated head injury: illustrative case. Journal of Neurosurgery Case Lessons. 6(8). 1 indexed citations
5.
Kanezaki, Rika, Tsutomu Toki, Kiminori Terui, et al.. (2022). Mechanism of KIT gene regulation by GATA1 lacking the N-terminal domain in Down syndrome–related myeloid disorders. Scientific Reports. 12(1). 20587–20587.
6.
Takahashi, Hiroyuki, Shiro Tanaka, Yuki Yuza, et al.. (2022). Safety and Efficacy of Arsenic Trioxide in the Treatment of Newly Diagnosed Pediatric Acute Promyelocytic Leukemia: Results from the JPLSG AML-P13 Study. Blood. 140(Supplement 1). 6160–6161. 1 indexed citations
7.
Aizawa, Tomomi, Tadaatsu Imaizumi, Koji Tsugawa, et al.. (2021). Effect of sera from lupus patients on the glomerular endothelial fibrinolysis system. Pediatrics International. 64(1). e15099–e15099. 1 indexed citations
8.
Moritake, Hiroshi, Shiro Tanaka, Takako Miyamura, et al.. (2020). The outcomes of relapsed acute myeloid leukemia in children: Results from the Japanese Pediatric Leukemia/Lymphoma Study Group AML‐05R study. Pediatric Blood & Cancer. 68(1). e28736–e28736. 12 indexed citations
9.
Nakashima, Kentaro, Daisuke Hasegawa, Daisuke Tomizawa, et al.. (2019). Characteristics and outcomes of children with acute myeloid leukemia and Down syndrome who are ineligible for clinical trials due to severe comorbidities. Pediatric Blood & Cancer. 66(11). e27942–e27942. 1 indexed citations
10.
Yoshida, Nao, Hirotoshi Sakaguchi, Miharu Yabe, et al.. (2019). Clinical Outcomes after Allogeneic Hematopoietic Stem Cell Transplantation in Children with Juvenile Myelomonocytic Leukemia: A Report from the Japan Society for Hematopoietic Cell Transplantation. Biology of Blood and Marrow Transplantation. 26(5). 902–910. 18 indexed citations
11.
Nakayama, Hideki, Daisuke Tomizawa, Shiro Tanaka, et al.. (2017). Fludarabine, cytarabine, granulocyte colony‐stimulating factor and idarubicin for relapsed childhood acute myeloid leukemia. Pediatrics International. 59(10). 1046–1052. 6 indexed citations
12.
Hiyama, Takeshi Y., Masahito Matsumoto, Akihiro Fujikawa, et al.. (2016). Adipsic hypernatremia without hypothalamic lesions accompanied by autoantibodies to subfornical organ. Brain Pathology. 27(3). 323–331. 23 indexed citations
13.
Sasahara, Yoji, Miki Sato, Hidetaka Niizuma, et al.. (2013). Selective expansion of donor‐derived regulatory T cells after allogeneic bone marrow transplantation in a patient with IPEX syndrome. Pediatric Transplantation. 18(1). E25–30. 18 indexed citations
14.
Tomizawa, Daisuke, Akio Tawa, Tomoyuki Watanabe, et al.. (2013). Appropriate dose reduction in induction therapy is essential for the treatment of infants with acute myeloid leukemia: a report from the Japanese Pediatric Leukemia/Lymphoma Study Group. International Journal of Hematology. 98(5). 578–588. 37 indexed citations
15.
Konno, Yoshihiro, Tsutomu Toki, Gang Xu, et al.. (2010). Mutations in the ribosomal protein genes in Japanese patients with Diamond-Blackfan anemia. Haematologica. 95(8). 1293–1299. 28 indexed citations
16.
Kanezaki, Rika, Tsutomu Toki, Kiminori Terui, et al.. (2010). Down syndrome and GATA1 mutations in transient abnormal myeloproliferative disorder: mutation classes correlate with progression to myeloid leukemia. Blood. 116(22). 4631–4638. 57 indexed citations
17.
Inoue, Akio, et al.. (2004). Negative regulation of γ-globin gene expression by cyclic AMP-dependent pathway in erythroid cells. Experimental Hematology. 32(3). 244–253. 28 indexed citations
18.
Kitazawa, Junichi, Yasuko Noda, Yoshihiro Takahashi, et al.. (2004). Hemolytic crisis with fulminant hepatic failure in Wilson disease without consanguinity. Pediatrics International. 46(6). 726–729. 9 indexed citations
19.
Toki, Tsutomu, Koji Arai, Kiminori Terui, et al.. (2000). Functional characterization of the two alternative promoters of human p45 NF-E2 gene. Experimental Hematology. 28(10). 1113–1119. 18 indexed citations
20.
Maeda, Masahiro, et al.. (1990). [Acute megakaryoblastic leukemia with complex chromosomal aberrations].. PubMed. 31(11). 1823–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel H. Wiseman Breakdown of academic impact, for papers by Anna Grazia Recchia Breakdown of academic impact, for papers by Jian‐Pei Fang Breakdown of academic impact, for papers by Sabine Knipp Breakdown of academic impact, for papers by A. O’Meara Breakdown of academic impact, for papers by Christine von Neuhoff Breakdown of academic impact, for papers by Sélim Corm Breakdown of academic impact, for papers by Maria de Lourdes Chauffaille Breakdown of academic impact, for papers by Sioḃán Keel Breakdown of academic impact, for papers by Kunitake Hirashima
Rankless by CCL
2026